PuraPharm Corporation Limited (HKG:1498)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.2800
+0.0050 (1.82%)
Jul 31, 2026, 4:08 PM HKT

PuraPharm Corporation Cash Flow Statement

Millions HKD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-35.22-35.44-106.08-120.21-121.88
Depreciation & Amortization
41.2552.4945.5745.8347.26
Other Amortization
3.282.15.334.23.13
Loss (Gain) From Sale of Assets
4.18-11.29-0.04-0.18
Asset Writedown & Restructuring Costs
1.292.7732.7141.3116
Loss (Gain) From Sale of Investments
0.57-1.440-0.17-0.3
Loss (Gain) on Equity Investments
0.090.310.15--
Stock-Based Compensation
-1.454.290.273.5
Provision & Write-off of Bad Debts
-8.16-12.7310.5517.03
Other Operating Activities
19.7930.4131.6125.6334.16
Change in Accounts Receivable
9.923.6147.09105.45-51.19
Change in Inventory
24.9850.37-6.44-17.234.68
Change in Accounts Payable
-50.27-10.8110.479.61-22.56
Change in Unearned Revenue
0.860.86-0.01-2.05-3.22
Change in Income Taxes
--5.84-4.17-
Change in Other Net Operating Assets
16-10.695.08-10.45-40.94
Operating Cash Flow
28.53103.9979.6188.51-14.52
Operating Cash Flow Growth
-72.57%30.62%-10.05%--

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.28-14.81-19.18-20.83-3.09
Sale of Property, Plant & Equipment
-3.48-0.12.89
Sale (Purchase) of Intangibles
-2.55-1.58-2.48-1.89-3.47
Investment in Securities
---0.63-1.98-
Other Investing Activities
26.961.194.09-6.649.67
Investing Cash Flow
24.12-11.71-18.2-31.256.01

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-3-5.552.16
Long-Term Debt Issued
154.7200.19253.03342.11374.88
Total Debt Issued
154.7203.19253.03347.66377.05
Short-Term Debt Repaid
---7.71--
Long-Term Debt Repaid
-200.6-266.38-340.29-359.87-363.89
Total Debt Repaid
-200.6-266.38-348-359.87-363.89
Net Debt Issued (Repaid)
-45.91-63.18-94.97-12.2113.16
Issuance of Common Stock
20--0.8-
Other Financing Activities
-20.43-23.25-27.42-24.18-27.03
Financing Cash Flow
-46.34-86.43-122.39-35.59-13.87

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.94-13.185.28-5.516.25
Net Cash Flow
3.38-7.33-55.7116.16-16.14

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
28.2489.1860.4367.68-17.61
Free Cash Flow Growth
-68.33%47.58%-10.72%--
Free Cash Flow Margin
8.40%23.34%14.85%15.10%-2.67%
Free Cash Flow Per Share
0.070.230.150.17-0.04
Levered Free Cash Flow
27.3666.2783.5282.33-36.52
Unlevered Free Cash Flow
40.3181.09100.6597.44-19.63

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
20.4323.2527.4224.1827.03
Cash Income Tax Paid
3.5-0.152.34.54.85
Change in Working Capital
1.4653.3362.0281.17-113.24